Compile Data Set for Download or QSAR
Report error Found 567 of affinity data for UniProtKB/TrEMBL: P98073
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628765(CHEMBL5415486)
Affinity DataIC50: 0.410nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628766(CHEMBL5433360)
Affinity DataIC50: 0.690nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595346(CHEMBL5189108)
Affinity DataIC50: 0.810nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595349(CHEMBL5202756)
Affinity DataIC50: 0.820nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595352(CHEMBL5175180)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595350(CHEMBL5182597)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628764(CHEMBL5418103)
Affinity DataIC50: 1.70nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595353(CHEMBL5179372)
Affinity DataIC50: 1.80nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628768(CHEMBL5398070)
Affinity DataIC50: 2.90nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595351(CHEMBL5200092)
Affinity DataIC50: 3.20nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628769(CHEMBL5428323)
Affinity DataIC50: 3.20nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628771(CHEMBL5407739)
Affinity DataIC50: 4.40nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595345(CHEMBL5182234)
Affinity DataIC50: 5.60nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595337(CHEMBL5195621)
Affinity DataIC50: 5.90nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595346(CHEMBL5189108)
Affinity DataIC50: 7.40nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595348(CHEMBL5170585)
Affinity DataIC50: 7.70nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595342(CHEMBL5170208)
Affinity DataIC50: 7.90nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628766(CHEMBL5433360)
Affinity DataIC50: 8.70nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628765(CHEMBL5415486)
Affinity DataIC50: 9.40nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595349(CHEMBL5202756)
Affinity DataIC50: 13nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595347(CHEMBL5169835)
Affinity DataIC50: 14nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595352(CHEMBL5175180)
Affinity DataIC50: 20nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628770(CHEMBL5413614)
Affinity DataIC50: 22nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595341(CHEMBL5202535)
Affinity DataIC50: 23nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595353(CHEMBL5179372)
Affinity DataIC50: 26nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628764(CHEMBL5418103)
Affinity DataIC50: 26nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595340(CHEMBL5173692)
Affinity DataIC50: 30nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595350(CHEMBL5182597)
Affinity DataIC50: 32nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595344(CHEMBL5182789)
Affinity DataIC50: 54nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595345(CHEMBL5182234)
Affinity DataIC50: 57nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595351(CHEMBL5200092)
Affinity DataIC50: 65nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628771(CHEMBL5407739)
Affinity DataIC50: 69nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628767(CHEMBL5418493)
Affinity DataIC50: 81nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595348(CHEMBL5170585)
Affinity DataIC50: 84nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628769(CHEMBL5428323)
Affinity DataIC50: 93nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595337(CHEMBL5195621)
Affinity DataIC50: 94nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628768(CHEMBL5398070)
Affinity DataIC50: 96nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595342(CHEMBL5170208)
Affinity DataIC50: 120nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595338(CHEMBL5190122)
Affinity DataIC50: 140nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595347(CHEMBL5169835)
Affinity DataIC50: 180nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595341(CHEMBL5202535)
Affinity DataIC50: 310nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595339(CHEMBL5205880)
Affinity DataIC50: 400nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628770(CHEMBL5413614)
Affinity DataIC50: 430nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595340(CHEMBL5173692)
Affinity DataIC50: 540nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595343(CHEMBL5188778)
Affinity DataIC50: 680nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628772(CHEMBL5401618)
Affinity DataIC50: 710nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595344(CHEMBL5182789)
Affinity DataIC50: 940nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595338(CHEMBL5190122)
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50628767(CHEMBL5418493)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of human recombinant enteropeptidase using 5FAM-Abu-Gly-Asp-Asp-Asp-Lys-Ile-Val-Gly-Gly-Lys(CPQ2)-Lys-Lys-NH2 as substrate incubated for 6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595343(CHEMBL5188778)
Affinity DataIC50: 3.30E+3nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
Displayed 1 to 50 (of 567 total ) | Next | Last >>
Jump to: